Professional Documents
Culture Documents
Drugs Affecting The Respiratory System
Drugs Affecting The Respiratory System
CLINICAL PHARMACY
PPL 237 / 3
Group Member
Farah Hani Bt.Rohizam
(PH003/08)
Nazrina Bt.Nasir Ahamed
(PH021/08)
Lecturer
Mr.Saminathan
DRUGS AFFECTING THE
RESPIRATORY SYSTEM
PRESENTED & PREPARED BY
FARAH HANI ROHIZAM
POINTS OF VIEW
– Infections
– Allergic Rhinitis
– Coughs
– Common Cold
– Congestion
LOWER RESPIRATORY REGION
Leukotriene Modifiers
ANTIHISTAMINE
ANTITUSSIVES, BRONCHODILATO
S&
MUCOLYTICS & RS & ANTI
DECONGESTAN
EXPECTORANTS ASTHMA DRUGS
TS
ANTIHISTAMINES &
DECONGESTANTS
USES
• Treatment of the congestion
associated with:
Common cold
Hay fever
Sinusitis
Allergic rhinitis
Congestion associated with rhinitis
DECONGESTANTS
ADVERSE REACTIONS
• Minimal effects when used topically
Nasal burning
Stinging
Dryness
• Oral decongestants
Tachycardia & other cardiac arryhthmias
Nervousness, restlessness, insomnia
Blurred vision
Nausea & vomiting
DECONGESTANTS
CONTRAINDICATIONS
• Patients with known hypersensitivity
chronic cough
These disorders interfere with the exchange
Emphysema
Salmeterol (Serevent)
Terbutaline (Brethine)
ANTIASTHMA DRUGS
• ICSs
• Mast Cell Stabilizer
• Leukotriene Formation Inhibitors
• Leukotriene Receptor Agonists
• Immunomodulators
BRONCHODILATORS
I. ADRENERGIC
BRONCHODILATORS
II. XANTHINE DERIVATIVES
ADRENERGIC BRONCHODILATORS
• Alpha (α)-adrenergic receptors (the sympathetic
system) in the lungs is stimulated,
bronchoconstriction results
• Bronchodilation occurs when β-adrenergic receptors
are stimulated
• Divided to
β2-adrenergic agonists (short acting – albuterol &
terbutaline)
β2-adrenergic agonists (long acting – salmeterol)
ADRENERGIC BRONCHODILATORS
ACTIONS
• When bronchospasm occurs
Decrease in lumen (inside diameter) of bronchi
Decrease amount of air taken into the lungs with each
breath
Results in respiratory distress
• Brochodilating drugs
Open bronchi by relaxing the smooth muscles
Allows more air to enter the lungs
Results in completely/partially relieves of respiratory
distress
ADRENERGIC BRONCHODILATORS
USES
• β2-adrenergic drugs (which mimic the sympathetic nervous
system) for treatment of COPD due to bronchoconstriction
such
Bronchospasm associated with acute & chronic bronchial asthma
Exercise-induced bronchospasm (EIB)
Bronchitis
Emphysema
Bronchiectasis (chronic dilation of the bronchi & bronchioles)
Other obsructive pulmonary disease
ADRENERGIC BRONCHODILATORS
ADVERSE REACTIONS
• Cardiovascular System Reactions
Tachycardia, palpitations, or cardiac arrythmias
Hypertension
• Other Reactions
Nervousness, anxiety
Insomnia
• If taken by inhalation, excessive use may result in
paradoxical bronchospasm
ADRENERGIC BRONCHODILATORS
CONTRAINDICATIONS
• Patients with known hypersensitivity
• Cardiac arrythmias associated with tachycardia
• Organic brain damage
• Narrow-angle glaucoma
• Salmeterol is contraindicated during acute
bronchospasm
ADRENERGIC BRONCHODILATORS
PRECAUTIONS
• Used cautiously in patients with
Hypertension
Cardiac dysfunction
Hyperthyroidism
Glaucoma
Diabetes
Prostatic hypertrophy
History of seizures
• Used cautiously during
Pregnancy (all in category C except Terbutaline in category B)
Lactation
ADRENERGIC BRONCHODILATORS
INTERACTIONS
EXAMPLES OF ADRENERGIC BRONCHODILATOR DRUGS
Drugs Brand Specific Side Effects Dosage Contra- Pregnanc
Name Class Forms indications y
Category
Albutero Proventil, selective Headache, Tablets, Threatened C
l beta-2- tremor, Syrups, abortion
Ventolin
adreno- tachycardia Evohaler, during 1st or
receptor , Respirato 2nd trimesters
agonists palpitations r of pregnancy.
, dizziness, solutions/ Toxaemia of
shakiness, Nebules, pregnancy,
hyperactivit IV placenta
y praevia,
antepartum
haemorrhage,
placenta
praevia
Salmeter Serevent selective Tremor, Tablet Patients with C
ol Diskus beta-2- headache, /Metered a history of
adreno- cough dose hypersensitivi
receptor inhaler or ty to any of
agonists dry the
powder ingredients of
XANTHINE DERIVATIVE
BRONCHODILATORS
• Inhaled Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Modifiers
• Immunomodulators
INHALED CORTICOSTEROIDS
(ICSs)
• Most consistently effective long-term medications
for persistent asthma
• ICS & LABA (Long Acting Beta Agonists) may be
combined to ease administration & produce positive
outcomes
• ACTIONS
– Anti-inflammatory that reduces airway
hyperresponsiveness
Reduce number of mast cells in airway
Block reaction to allergens
– Beclomethasone (QVAR), flunisolide (AeroBid), &
triamcinolone (Azmacort) are given by inhalation
Decrease the inflammatory process directly in the airways
– Corticosteroid increase sensitivity of β2 receptors
Increase the effectiveness of β2 receptor agonist drugs
USES OF ICSs
• Management & prophylactic treatment of
the inflammation associated with chronic
asthma
• Some may be used intranasally for
treatment of nasal polyps & rhinitis
ADVERSE REACTIONS
• ACTIONS
They are thought to stabilize the mast cell membrane
Possibly by preventing calcium ions from entering mast
cells
Preventing release of inflammatory mediators such as
histamines & leukotrienes
• USES
Used in combination with other drugs
In treatment of Asthma & allergic disorders
Includes allergic rhinitis (nasal solution)
Used to prevent EIB (Exercise-Induced Bronchospasm)
Typically used in step 2 care for chronic asthma
ADVERSE REACTIONS
• Respiratory System Reactions
Throat irritation & dryness
Unpleasant taste sensation
Cough or wheeze
May cause nauseated feeling
CONTRAINDICATIONS & PRECAUTIONS
Patients with
Known hypersensitivity
During attacks of acute asthma cause may worsen bronchospasm
Used to cautiously in
Pregnancy (Category B)
Lactation
Patients with impaired renal or hepatic function
EXAMPLES OF MAST CELL STABILIZERS DRUGS